| Dr Brooke Lester Darmstadter, PHARMD | |
|
26351 Patriots Way, 102 Lloyd Lane, Georgetown, DE 19947-2575 | |
| (302) 933-3420 | |
| (302) 933-3421 |
| Full Name | Dr Brooke Lester Darmstadter |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 26351 Patriots Way, Georgetown, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750651071 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | A10003320 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brooke Lester Darmstadter, PHARMD 26351 Patriots Way, 102 Lloyd Lane, Georgetown, DE 19947-2575 Ph: (302) 933-3420 | Dr Brooke Lester Darmstadter, PHARMD 26351 Patriots Way, 102 Lloyd Lane, Georgetown, DE 19947-2575 Ph: (302) 933-3420 |
News Archive
Efforts to improve depression care in Minnesota and surrounding areas will benefit from a first-of-its-kind quality measure introduced this week by MN Community Measurement, a nonprofit organization that provides objective information on the quality of health care through its Web site.
An international study of more than 3.2 million people with severe mental illness reveals a substantially increased risk for developing cardiovascular disease compared to the general population.
More good news for pistachio fans! According to new data unveiled this week at the Experimental Biology Conference in San Diego, snacking on pistachios has proved once again to have a positive impact on improving cardiovascular health by significantly reducing inflammation in the body, a prominent cardiovascular disease (CVD) risk factor.
Researchers found a negative association between the number of excess deaths during the first wave of the epidemic and the number of second-wave cases. This could be because of both a sort of herd immunity and changes in behavioral response.
The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.
› Verified 7 days ago
Patrick E Costantino, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 College Park Ln, Georgetown, DE 19947 Phone: 302-854-9464 | |
Ann Marie Mongeluzo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 Georgetown Plz, Georgetown, DE 19947 Phone: 302-856-2015 | |
Mr. Andrea Meyer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Haven Dr, Georgetown, DE 19947 Phone: 302-745-8823 | |
Lakshmi Veerareddy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 432 E Market St, Georgetown, DE 19947 Phone: 302-856-2828 | |
Gillian Ndi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2 College Park Ln, Georgetown, DE 19947 Phone: 302-854-5200 | |
David Dowling, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2 College Park Ln, Georgetown, DE 19947 Phone: 302-853-5200 |